Related references
Note: Only part of the references are listed.In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases
Yee-Huang Ku et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan
Chung-Chih Lai et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems
N. Y. Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Detection of NDM-1-Producing Klebsiella pneumoniae in Kenya
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence
Yu-Kuo Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Prevalence and Characteristics of Ertapenem-Resistant Klebsiella pneumoniae Isolates in a Taiwanese University Hospital
Jiunn-Jong Wu et al.
MICROBIAL DRUG RESISTANCE (2011)
Development of High-Level Carbapenem Resistance in Klebsiella pneumoniae Among Patients with Prolonged Hospitalization and Carbapenem Exposure
Ju-Hsin Chia et al.
MICROBIAL DRUG RESISTANCE (2010)
Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?
Maria Souli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
BSAC standardized disc susceptibility testing method (version 8)
J. M. Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Optimizing therapy for infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases
Andrea Endimiani et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Detection of a new SHV-type extended-spectrum β-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in the Netherlands
A. Mazzariol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan
PR Hsueh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli
T Yagi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France
C Eckert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae
KS Thomson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
